open access

Vol 6, No 3 (2005): Practical Diabetology
Original articles (submitted)
Published online: 2005-05-16
Get Citation

Risk of diabetes mellitus after gestational diabetes - review. Part II. Predisposition to diabetes mellitus and postparum care of women with previous gestational diabetes

Aneta Malinowska-Polubiec, Krzysztof Czajkowski
Diabetologia Praktyczna 2005;6(3):136-140.

open access

Vol 6, No 3 (2005): Practical Diabetology
Original articles (submitted)
Published online: 2005-05-16

Abstract

Gestational diabetes mellitus with impaired fasting glucose and impaired glucose tolerance increase risk of developing overt diabetes later in life. Obesity increased the risk of diabetes type 2. Inslet cell antibodies are markers for subject at risk for type 1 diabetes melitus after GDM. Women with previous GDM also have a high risk of insulin metabolic syndrome: increased BMI, dyslipidemia, hypertension and subsequently increased risk of atherosclerosis and coronary heart disease. The primary goal in the care of women with previous GDM is to prevent the development of diabetes and diabetic sequelae. All women after GDM should have a regular assessment of their glucose tolerance in the years after pregnancy. Currently, there are no recommended medical strategies to prevent the development of diabetes in women with previous GDM. The current glycemic status of women with recent GDM should be established (oral glucose tolerance test) at the postpartum visit and then, at minimum, every 2–4 years thereafter. Equally important is the long-term lifestyle changes (nutritional managenent and exercise programs) that may maintain or achieve normal or reasonable body weight.

Abstract

Gestational diabetes mellitus with impaired fasting glucose and impaired glucose tolerance increase risk of developing overt diabetes later in life. Obesity increased the risk of diabetes type 2. Inslet cell antibodies are markers for subject at risk for type 1 diabetes melitus after GDM. Women with previous GDM also have a high risk of insulin metabolic syndrome: increased BMI, dyslipidemia, hypertension and subsequently increased risk of atherosclerosis and coronary heart disease. The primary goal in the care of women with previous GDM is to prevent the development of diabetes and diabetic sequelae. All women after GDM should have a regular assessment of their glucose tolerance in the years after pregnancy. Currently, there are no recommended medical strategies to prevent the development of diabetes in women with previous GDM. The current glycemic status of women with recent GDM should be established (oral glucose tolerance test) at the postpartum visit and then, at minimum, every 2–4 years thereafter. Equally important is the long-term lifestyle changes (nutritional managenent and exercise programs) that may maintain or achieve normal or reasonable body weight.
Get Citation

Keywords

gestational diabetes mellitus; predisposition to diabetes

About this article
Title

Risk of diabetes mellitus after gestational diabetes - review. Part II. Predisposition to diabetes mellitus and postparum care of women with previous gestational diabetes

Journal

Clinical Diabetology

Issue

Vol 6, No 3 (2005): Practical Diabetology

Pages

136-140

Published online

2005-05-16

Bibliographic record

Diabetologia Praktyczna 2005;6(3):136-140.

Keywords

gestational diabetes mellitus
predisposition to diabetes

Authors

Aneta Malinowska-Polubiec
Krzysztof Czajkowski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Diabetologia Kliniczna dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl